alpha-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer
Genetic-driven deregulation of the Wnt pathway is crucial but not sufficient for colorectal cancer (CRC) tumorigenesis. Here, we show that environmental glutamine restriction further augments Wnt signaling in APC-mutant intestinal organoids to promote stemness, and leads to adenocarcinoma formation...
Gespeichert in:
Veröffentlicht in: | Nature cancer 2020-03, Vol.1 (3), p.345-358 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 358 |
---|---|
container_issue | 3 |
container_start_page | 345 |
container_title | Nature cancer |
container_volume | 1 |
creator | Tran, Thai Q. Hanse, Eric A. Habowski, Amber N. Li, Haiqing Gabra, Mari B. Ishak Yang, Ying Lowman, Xazmin H. Ooi, Amelia M. Liao, Shu Y. Edwards, Robert A. Waterman, Marian L. Kong, Mei |
description | Genetic-driven deregulation of the Wnt pathway is crucial but not sufficient for colorectal cancer (CRC) tumorigenesis. Here, we show that environmental glutamine restriction further augments Wnt signaling in APC-mutant intestinal organoids to promote stemness, and leads to adenocarcinoma formation in vivo via decreasing intracellular alpha-ketoglutarate (alpha KG) levels. alpha KG supplementation is sufficient to rescue low-glutamine-induced stemness and Wnt hyperactivation. Mechanistically, we found that alpha KG promotes hypomethylation of DNA and histone H3K4me3, leading to an upregulation of differentiation-associated genes and downregulation of Wnt target genes, respectively. Using organoids derived from patients with CRC and several in vivo CRC tumor models, we show that alpha KG supplementation suppresses Wnt signaling and promotes cellular differentiation, thereby significantly restricting tumor growth and extending survival. Together, our results reveal how the metabolic microenvironment impacts Wnt signaling and identify alpha KG as a potent antineoplastic metabolite for potential differentiation therapy for patients with CRC. |
doi_str_mv | 10.1038/s43018-020-0035-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2436876129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2436876129</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-7dea28977958c1643cfcbdd9a6e5271d3d03af0acf5b87d0d39393d1075154383</originalsourceid><addsrcrecordid>eNqNkUGLFDEQhYMo7jLuD_AifRSk10rS6SQXQYbVFRe8KF6EUJOkZyM9yZikV_z3Zpx1WG-SQx7Uq1dFfYQ8p3BJgavXZeBAVQ8MegAuevGInLNxZD3lg3z8QJ-Ri1K-AwATlAqtnpIzzhRnmqpz8g3n_S32H31N23mpmLH6Dmv1cWmqdF9j7UrYRpxD3HYYXedyuGsFF6bJZx9rwBpS7ELsbJpT9rbi3FmM1udn5MmEc_EX9_-KfHl39Xl93d98ev9h_famt1zr2kvnkSktpRbK0nHgdrIb5zSOXjBJHXfAcQK0k9go6cBx3Z6jIAUVA1d8Rd4cc_fLZuedbVtlnM0-hx3mXyZhMP9WYrg123Rn5DAwBoeAl_cBOf1YfKlmF4r184zRp6UYNvBRyZEy3az0aLU5lZL9dBpDwRzAmCMY08CYAxgjWs-Lh_udOv5iaIZXR8NPv0lTscG3851sDd0ICqhuAtqIFVH_716H-gfQOi2x8t9V9qvU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2436876129</pqid></control><display><type>article</type><title>alpha-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer</title><source>MEDLINE</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>Alma/SFX Local Collection</source><creator>Tran, Thai Q. ; Hanse, Eric A. ; Habowski, Amber N. ; Li, Haiqing ; Gabra, Mari B. Ishak ; Yang, Ying ; Lowman, Xazmin H. ; Ooi, Amelia M. ; Liao, Shu Y. ; Edwards, Robert A. ; Waterman, Marian L. ; Kong, Mei</creator><creatorcontrib>Tran, Thai Q. ; Hanse, Eric A. ; Habowski, Amber N. ; Li, Haiqing ; Gabra, Mari B. Ishak ; Yang, Ying ; Lowman, Xazmin H. ; Ooi, Amelia M. ; Liao, Shu Y. ; Edwards, Robert A. ; Waterman, Marian L. ; Kong, Mei</creatorcontrib><description>Genetic-driven deregulation of the Wnt pathway is crucial but not sufficient for colorectal cancer (CRC) tumorigenesis. Here, we show that environmental glutamine restriction further augments Wnt signaling in APC-mutant intestinal organoids to promote stemness, and leads to adenocarcinoma formation in vivo via decreasing intracellular alpha-ketoglutarate (alpha KG) levels. alpha KG supplementation is sufficient to rescue low-glutamine-induced stemness and Wnt hyperactivation. Mechanistically, we found that alpha KG promotes hypomethylation of DNA and histone H3K4me3, leading to an upregulation of differentiation-associated genes and downregulation of Wnt target genes, respectively. Using organoids derived from patients with CRC and several in vivo CRC tumor models, we show that alpha KG supplementation suppresses Wnt signaling and promotes cellular differentiation, thereby significantly restricting tumor growth and extending survival. Together, our results reveal how the metabolic microenvironment impacts Wnt signaling and identify alpha KG as a potent antineoplastic metabolite for potential differentiation therapy for patients with CRC.</description><identifier>ISSN: 2662-1347</identifier><identifier>EISSN: 2662-1347</identifier><identifier>DOI: 10.1038/s43018-020-0035-5</identifier><identifier>PMID: 32832918</identifier><language>eng</language><publisher>BERLIN: NATURE PORTFOLIO</publisher><subject>Colorectal Neoplasms - drug therapy ; Glutamine ; Humans ; Ketoglutaric Acids - pharmacology ; Life Sciences & Biomedicine ; Oncology ; Organoids ; Science & Technology ; Tumor Microenvironment ; Wnt Signaling Pathway - genetics</subject><ispartof>Nature cancer, 2020-03, Vol.1 (3), p.345-358</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>88</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000608019000010</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c399t-7dea28977958c1643cfcbdd9a6e5271d3d03af0acf5b87d0d39393d1075154383</citedby><cites>FETCH-LOGICAL-c399t-7dea28977958c1643cfcbdd9a6e5271d3d03af0acf5b87d0d39393d1075154383</cites><orcidid>0000-0002-1234-0198 ; 0000-0003-1107-3208 ; 0000-0001-7559-0525 ; 0000-0001-5583-2240 ; 0000-0001-8139-2349</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,782,786,887,27933,27934,28257</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32832918$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tran, Thai Q.</creatorcontrib><creatorcontrib>Hanse, Eric A.</creatorcontrib><creatorcontrib>Habowski, Amber N.</creatorcontrib><creatorcontrib>Li, Haiqing</creatorcontrib><creatorcontrib>Gabra, Mari B. Ishak</creatorcontrib><creatorcontrib>Yang, Ying</creatorcontrib><creatorcontrib>Lowman, Xazmin H.</creatorcontrib><creatorcontrib>Ooi, Amelia M.</creatorcontrib><creatorcontrib>Liao, Shu Y.</creatorcontrib><creatorcontrib>Edwards, Robert A.</creatorcontrib><creatorcontrib>Waterman, Marian L.</creatorcontrib><creatorcontrib>Kong, Mei</creatorcontrib><title>alpha-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer</title><title>Nature cancer</title><addtitle>NAT CANCER</addtitle><addtitle>Nat Cancer</addtitle><description>Genetic-driven deregulation of the Wnt pathway is crucial but not sufficient for colorectal cancer (CRC) tumorigenesis. Here, we show that environmental glutamine restriction further augments Wnt signaling in APC-mutant intestinal organoids to promote stemness, and leads to adenocarcinoma formation in vivo via decreasing intracellular alpha-ketoglutarate (alpha KG) levels. alpha KG supplementation is sufficient to rescue low-glutamine-induced stemness and Wnt hyperactivation. Mechanistically, we found that alpha KG promotes hypomethylation of DNA and histone H3K4me3, leading to an upregulation of differentiation-associated genes and downregulation of Wnt target genes, respectively. Using organoids derived from patients with CRC and several in vivo CRC tumor models, we show that alpha KG supplementation suppresses Wnt signaling and promotes cellular differentiation, thereby significantly restricting tumor growth and extending survival. Together, our results reveal how the metabolic microenvironment impacts Wnt signaling and identify alpha KG as a potent antineoplastic metabolite for potential differentiation therapy for patients with CRC.</description><subject>Colorectal Neoplasms - drug therapy</subject><subject>Glutamine</subject><subject>Humans</subject><subject>Ketoglutaric Acids - pharmacology</subject><subject>Life Sciences & Biomedicine</subject><subject>Oncology</subject><subject>Organoids</subject><subject>Science & Technology</subject><subject>Tumor Microenvironment</subject><subject>Wnt Signaling Pathway - genetics</subject><issn>2662-1347</issn><issn>2662-1347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>EIF</sourceid><recordid>eNqNkUGLFDEQhYMo7jLuD_AifRSk10rS6SQXQYbVFRe8KF6EUJOkZyM9yZikV_z3Zpx1WG-SQx7Uq1dFfYQ8p3BJgavXZeBAVQ8MegAuevGInLNxZD3lg3z8QJ-Ri1K-AwATlAqtnpIzzhRnmqpz8g3n_S32H31N23mpmLH6Dmv1cWmqdF9j7UrYRpxD3HYYXedyuGsFF6bJZx9rwBpS7ELsbJpT9rbi3FmM1udn5MmEc_EX9_-KfHl39Xl93d98ev9h_famt1zr2kvnkSktpRbK0nHgdrIb5zSOXjBJHXfAcQK0k9go6cBx3Z6jIAUVA1d8Rd4cc_fLZuedbVtlnM0-hx3mXyZhMP9WYrg123Rn5DAwBoeAl_cBOf1YfKlmF4r184zRp6UYNvBRyZEy3az0aLU5lZL9dBpDwRzAmCMY08CYAxgjWs-Lh_udOv5iaIZXR8NPv0lTscG3851sDd0ICqhuAtqIFVH_716H-gfQOi2x8t9V9qvU</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Tran, Thai Q.</creator><creator>Hanse, Eric A.</creator><creator>Habowski, Amber N.</creator><creator>Li, Haiqing</creator><creator>Gabra, Mari B. Ishak</creator><creator>Yang, Ying</creator><creator>Lowman, Xazmin H.</creator><creator>Ooi, Amelia M.</creator><creator>Liao, Shu Y.</creator><creator>Edwards, Robert A.</creator><creator>Waterman, Marian L.</creator><creator>Kong, Mei</creator><general>NATURE PORTFOLIO</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1234-0198</orcidid><orcidid>https://orcid.org/0000-0003-1107-3208</orcidid><orcidid>https://orcid.org/0000-0001-7559-0525</orcidid><orcidid>https://orcid.org/0000-0001-5583-2240</orcidid><orcidid>https://orcid.org/0000-0001-8139-2349</orcidid></search><sort><creationdate>20200301</creationdate><title>alpha-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer</title><author>Tran, Thai Q. ; Hanse, Eric A. ; Habowski, Amber N. ; Li, Haiqing ; Gabra, Mari B. Ishak ; Yang, Ying ; Lowman, Xazmin H. ; Ooi, Amelia M. ; Liao, Shu Y. ; Edwards, Robert A. ; Waterman, Marian L. ; Kong, Mei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-7dea28977958c1643cfcbdd9a6e5271d3d03af0acf5b87d0d39393d1075154383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Colorectal Neoplasms - drug therapy</topic><topic>Glutamine</topic><topic>Humans</topic><topic>Ketoglutaric Acids - pharmacology</topic><topic>Life Sciences & Biomedicine</topic><topic>Oncology</topic><topic>Organoids</topic><topic>Science & Technology</topic><topic>Tumor Microenvironment</topic><topic>Wnt Signaling Pathway - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tran, Thai Q.</creatorcontrib><creatorcontrib>Hanse, Eric A.</creatorcontrib><creatorcontrib>Habowski, Amber N.</creatorcontrib><creatorcontrib>Li, Haiqing</creatorcontrib><creatorcontrib>Gabra, Mari B. Ishak</creatorcontrib><creatorcontrib>Yang, Ying</creatorcontrib><creatorcontrib>Lowman, Xazmin H.</creatorcontrib><creatorcontrib>Ooi, Amelia M.</creatorcontrib><creatorcontrib>Liao, Shu Y.</creatorcontrib><creatorcontrib>Edwards, Robert A.</creatorcontrib><creatorcontrib>Waterman, Marian L.</creatorcontrib><creatorcontrib>Kong, Mei</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nature cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tran, Thai Q.</au><au>Hanse, Eric A.</au><au>Habowski, Amber N.</au><au>Li, Haiqing</au><au>Gabra, Mari B. Ishak</au><au>Yang, Ying</au><au>Lowman, Xazmin H.</au><au>Ooi, Amelia M.</au><au>Liao, Shu Y.</au><au>Edwards, Robert A.</au><au>Waterman, Marian L.</au><au>Kong, Mei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>alpha-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer</atitle><jtitle>Nature cancer</jtitle><stitle>NAT CANCER</stitle><addtitle>Nat Cancer</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>1</volume><issue>3</issue><spage>345</spage><epage>358</epage><pages>345-358</pages><issn>2662-1347</issn><eissn>2662-1347</eissn><abstract>Genetic-driven deregulation of the Wnt pathway is crucial but not sufficient for colorectal cancer (CRC) tumorigenesis. Here, we show that environmental glutamine restriction further augments Wnt signaling in APC-mutant intestinal organoids to promote stemness, and leads to adenocarcinoma formation in vivo via decreasing intracellular alpha-ketoglutarate (alpha KG) levels. alpha KG supplementation is sufficient to rescue low-glutamine-induced stemness and Wnt hyperactivation. Mechanistically, we found that alpha KG promotes hypomethylation of DNA and histone H3K4me3, leading to an upregulation of differentiation-associated genes and downregulation of Wnt target genes, respectively. Using organoids derived from patients with CRC and several in vivo CRC tumor models, we show that alpha KG supplementation suppresses Wnt signaling and promotes cellular differentiation, thereby significantly restricting tumor growth and extending survival. Together, our results reveal how the metabolic microenvironment impacts Wnt signaling and identify alpha KG as a potent antineoplastic metabolite for potential differentiation therapy for patients with CRC.</abstract><cop>BERLIN</cop><pub>NATURE PORTFOLIO</pub><pmid>32832918</pmid><doi>10.1038/s43018-020-0035-5</doi><tpages>30</tpages><orcidid>https://orcid.org/0000-0002-1234-0198</orcidid><orcidid>https://orcid.org/0000-0003-1107-3208</orcidid><orcidid>https://orcid.org/0000-0001-7559-0525</orcidid><orcidid>https://orcid.org/0000-0001-5583-2240</orcidid><orcidid>https://orcid.org/0000-0001-8139-2349</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2662-1347 |
ispartof | Nature cancer, 2020-03, Vol.1 (3), p.345-358 |
issn | 2662-1347 2662-1347 |
language | eng |
recordid | cdi_proquest_miscellaneous_2436876129 |
source | MEDLINE; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; Alma/SFX Local Collection |
subjects | Colorectal Neoplasms - drug therapy Glutamine Humans Ketoglutaric Acids - pharmacology Life Sciences & Biomedicine Oncology Organoids Science & Technology Tumor Microenvironment Wnt Signaling Pathway - genetics |
title | alpha-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T08%3A08%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=alpha-Ketoglutarate%20attenuates%20Wnt%20signaling%20and%20drives%20differentiation%20in%20colorectal%20cancer&rft.jtitle=Nature%20cancer&rft.au=Tran,%20Thai%20Q.&rft.date=2020-03-01&rft.volume=1&rft.issue=3&rft.spage=345&rft.epage=358&rft.pages=345-358&rft.issn=2662-1347&rft.eissn=2662-1347&rft_id=info:doi/10.1038/s43018-020-0035-5&rft_dat=%3Cproquest_pubme%3E2436876129%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2436876129&rft_id=info:pmid/32832918&rfr_iscdi=true |